annual CFO:
$4.42B-$173.50M(-3.78%)Summary
- As of today (May 29, 2025), REGN annual cash flow from operations is $4.42 billion, with the most recent change of -$173.50 million (-3.78%) on December 31, 2024.
- During the last 3 years, REGN annual CFO has fallen by -$2.66 billion (-37.58%).
- REGN annual CFO is now -37.58% below its all-time high of $7.08 billion, reached on December 31, 2021.
Performance
REGN Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$1.05B-$217.70M(-17.24%)Summary
- As of today (May 29, 2025), REGN quarterly cash flow from operations is $1.05 billion, with the most recent change of -$217.70 million (-17.24%) on March 31, 2025.
- Over the past year, REGN quarterly CFO has dropped by -$467.40 million (-30.90%).
- REGN quarterly CFO is now -69.38% below its all-time high of $3.41 billion, reached on September 30, 2021.
Performance
REGN quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$3.95B-$467.40M(-10.57%)Summary
- As of today (May 29, 2025), REGN TTM cash flow from operations is $3.95 billion, with the most recent change of -$467.40 million (-10.57%) on March 31, 2025.
- Over the past year, REGN TTM CFO has dropped by -$785.80 million (-16.58%).
- REGN TTM CFO is now -53.57% below its all-time high of $8.51 billion, reached on March 31, 2022.
Performance
REGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
REGN Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -3.8% | -30.9% | -16.6% |
3 y3 years | -37.6% | -50.3% | -53.6% |
5 y5 years | +81.9% | +49.7% | +77.2% |
REGN Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -37.6% | at low | -50.3% | +195.2% | -53.6% | at low |
5 y | 5-year | -37.6% | +81.9% | -69.4% | +511.0% | -53.6% | +81.8% |
alltime | all time | -37.6% | +3220.0% | -69.4% | +511.0% | -53.6% | +1606.1% |
REGN Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $1.05B(-17.2%) | $3.95B(-10.6%) |
Dec 2024 | $4.42B(-3.8%) | $1.26B(-2.2%) | $4.42B(+4.1%) |
Sep 2024 | - | $1.29B(+264.7%) | $4.25B(+4.3%) |
Jun 2024 | - | $354.00M(-76.6%) | $4.07B(-14.1%) |
Mar 2024 | - | $1.51B(+38.8%) | $4.74B(+3.2%) |
Dec 2023 | $4.59B(-8.4%) | $1.09B(-2.2%) | $4.59B(-12.1%) |
Sep 2023 | - | $1.11B(+9.0%) | $5.22B(+10.2%) |
Jun 2023 | - | $1.02B(-25.2%) | $4.74B(+10.7%) |
Mar 2023 | - | $1.37B(-20.5%) | $4.28B(-14.6%) |
Dec 2022 | $5.01B(-29.2%) | $1.72B(+173.5%) | $5.01B(-11.5%) |
Sep 2022 | - | $628.90M(+11.4%) | $5.67B(-32.9%) |
Jun 2022 | - | $564.40M(-73.1%) | $8.45B(-0.7%) |
Mar 2022 | - | $2.10B(-11.4%) | $8.51B(+20.2%) |
Dec 2021 | $7.08B(+170.5%) | $2.37B(-30.5%) | $7.08B(+19.2%) |
Sep 2021 | - | $3.41B(+444.7%) | $5.94B(+161.4%) |
Jun 2021 | - | $626.70M(-6.3%) | $2.27B(-12.2%) |
Mar 2021 | - | $668.50M(-45.7%) | $2.59B(-1.1%) |
Dec 2020 | $2.62B(+7.7%) | $1.23B(-584.1%) | $2.62B(+20.4%) |
Sep 2020 | - | -$254.30M(-127.0%) | $2.17B(-27.2%) |
Jun 2020 | - | $943.40M(+35.2%) | $2.99B(+33.8%) |
Mar 2020 | - | $698.00M(-11.4%) | $2.23B(-8.2%) |
Dec 2019 | $2.43B(+10.7%) | $787.40M(+41.3%) | $2.43B(+2.5%) |
Sep 2019 | - | $557.30M(+196.0%) | $2.37B(+4.6%) |
Jun 2019 | - | $188.30M(-79.0%) | $2.27B(-8.3%) |
Mar 2019 | - | $897.00M(+23.1%) | $2.47B(+12.7%) |
Dec 2018 | $2.20B(+67.9%) | $728.80M(+60.9%) | $2.20B(+8.0%) |
Sep 2018 | - | $452.90M(+14.8%) | $2.03B(+1.9%) |
Jun 2018 | - | $394.60M(-36.2%) | $2.00B(+27.1%) |
Mar 2018 | - | $618.80M(+9.1%) | $1.57B(+20.1%) |
Dec 2017 | $1.31B(-12.0%) | $566.94M(+36.7%) | $1.31B(+15.6%) |
Sep 2017 | - | $414.83M(-1457.0%) | $1.13B(-17.3%) |
Jun 2017 | - | -$30.57M(-108.6%) | $1.37B(-23.9%) |
Mar 2017 | - | $355.90M(-8.8%) | $1.80B(+20.9%) |
Dec 2016 | $1.49B(+11.7%) | $390.38M(-40.0%) | $1.49B(+7.9%) |
Sep 2016 | - | $651.03M(+63.0%) | $1.38B(-14.9%) |
Jun 2016 | - | $399.50M(+788.0%) | $1.62B(+9.6%) |
Mar 2016 | - | $44.99M(-84.0%) | $1.48B(+11.0%) |
Dec 2015 | $1.33B(+76.9%) | $281.82M(-68.4%) | $1.33B(+6.7%) |
Sep 2015 | - | $892.85M(+246.3%) | $1.25B(+140.5%) |
Jun 2015 | - | $257.83M(-353.5%) | $518.60M(-13.2%) |
Mar 2015 | - | -$101.73M(-151.3%) | $597.18M(-20.6%) |
Dec 2014 | $752.43M(+27.8%) | $198.18M(+20.6%) | $752.43M(-10.0%) |
Sep 2014 | - | $164.32M(-51.2%) | $835.99M(+9.4%) |
Jun 2014 | - | $336.41M(+528.5%) | $764.12M(+37.5%) |
Mar 2014 | - | $53.53M(-81.0%) | $555.88M(-5.6%) |
Dec 2013 | $588.60M(-888.8%) | $281.73M(+204.7%) | $588.60M(+47.1%) |
Sep 2013 | - | $92.45M(-27.9%) | $400.05M(+31.1%) |
Jun 2013 | - | $128.16M(+48.6%) | $305.21M(+209.3%) |
Mar 2013 | - | $86.25M(-7.4%) | $98.67M(-232.2%) |
Dec 2012 | -$74.61M(-47.3%) | $93.19M(-4012.0%) | -$74.61M(-65.8%) |
Sep 2012 | - | -$2.38M(-97.0%) | -$218.12M(-16.9%) |
Jun 2012 | - | -$78.38M(-10.0%) | -$262.47M(+20.3%) |
Mar 2012 | - | -$87.04M(+73.0%) | -$218.14M(+54.0%) |
Dec 2011 | -$141.68M(-242.8%) | -$50.32M(+7.7%) | -$141.68M(+7.2%) |
Sep 2011 | - | -$46.73M(+37.3%) | -$132.22M(-273.9%) |
Jun 2011 | - | -$34.05M(+221.8%) | $76.02M(-22.6%) |
Mar 2011 | - | -$10.58M(-74.1%) | $98.22M(-1.0%) |
Dec 2010 | $99.22M(-237.4%) | -$40.85M(-125.3%) | $99.22M(+5.9%) |
Sep 2010 | - | $161.50M(-1462.9%) | $93.67M(-220.6%) |
Jun 2010 | - | -$11.85M(+23.7%) | -$77.65M(+16.9%) |
Mar 2010 | - | -$9.58M(-79.4%) | -$66.43M(-8.0%) |
Dec 2009 | -$72.23M(-18.9%) | -$46.40M(+372.4%) | -$72.23M(+17.1%) |
Sep 2009 | - | -$9.82M(+1476.6%) | -$61.67M(-34.0%) |
Jun 2009 | - | -$623.00K(-95.9%) | -$93.39M(+7.9%) |
Mar 2009 | - | -$15.38M(-57.1%) | -$86.57M(-2.8%) |
Dec 2008 | -$89.09M | -$35.84M(-13.7%) | -$89.09M(+3567.6%) |
Sep 2008 | - | -$41.55M(-770.4%) | -$2.43M(-108.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2008 | - | $6.20M(-134.6%) | $28.42M(+51.9%) |
Mar 2008 | - | -$17.90M(-135.2%) | $18.71M(-31.6%) |
Dec 2007 | $27.37M(+18.6%) | $50.82M(-574.9%) | $27.37M(-8.3%) |
Sep 2007 | - | -$10.70M(+205.1%) | $29.86M(+16.1%) |
Jun 2007 | - | -$3.51M(-62.0%) | $25.73M(+200.6%) |
Mar 2007 | - | -$9.24M(-117.3%) | $8.56M(-62.9%) |
Dec 2006 | $23.07M(-176.2%) | $53.30M(-459.4%) | $23.07M(-146.1%) |
Sep 2006 | - | -$14.83M(-28.3%) | -$50.08M(-0.3%) |
Jun 2006 | - | -$20.68M(-491.7%) | -$50.24M(-13.6%) |
Mar 2006 | - | $5.28M(-126.6%) | -$58.15M(+91.9%) |
Dec 2005 | -$30.30M(+79.2%) | -$19.85M(+32.3%) | -$30.30M(+33.8%) |
Sep 2005 | - | -$15.00M(-47.5%) | -$22.65M(+101.6%) |
Jun 2005 | - | -$28.58M(-186.3%) | -$11.24M(-132.3%) |
Mar 2005 | - | $33.13M(-371.6%) | $34.80M(-305.8%) |
Dec 2004 | -$16.91M(+175.7%) | -$12.20M(+240.2%) | -$16.91M(-49.0%) |
Sep 2004 | - | -$3.59M(-120.5%) | -$33.14M(-202.7%) |
Jun 2004 | - | $17.46M(-194.0%) | $32.26M(-224.5%) |
Mar 2004 | - | -$18.58M(-34.6%) | -$25.91M(+322.4%) |
Dec 2003 | -$6.13M(-94.5%) | -$28.43M(-146.0%) | -$6.13M(-29.7%) |
Sep 2003 | - | $61.81M(-251.8%) | -$8.73M(-90.8%) |
Jun 2003 | - | -$40.71M(-3512.2%) | -$94.39M(+13.4%) |
Mar 2003 | - | $1.19M(-103.8%) | -$83.28M(-24.7%) |
Dec 2002 | -$110.52M(+92.8%) | -$31.03M(+30.1%) | -$110.52M(+13.8%) |
Sep 2002 | - | -$23.85M(-19.4%) | -$97.15M(+2.1%) |
Jun 2002 | - | -$29.59M(+13.6%) | -$95.19M(+27.0%) |
Mar 2002 | - | -$26.05M(+47.6%) | -$74.98M(+30.8%) |
Dec 2001 | -$57.32M(+105.4%) | -$17.65M(-19.4%) | -$57.32M(+32.0%) |
Sep 2001 | - | -$21.89M(+133.4%) | -$43.44M(+70.1%) |
Jun 2001 | - | -$9.38M(+11.7%) | -$25.53M(+29.5%) |
Mar 2001 | - | -$8.40M(+122.7%) | -$19.72M(-29.3%) |
Dec 2000 | -$27.91M(+106.7%) | -$3.77M(-5.4%) | -$27.91M(+65.7%) |
Sep 2000 | - | -$3.99M(+11.7%) | -$16.84M(-18.1%) |
Jun 2000 | - | -$3.57M(-78.5%) | -$20.55M(-5.2%) |
Mar 2000 | - | -$16.59M(-327.2%) | -$21.69M(+60.6%) |
Dec 1999 | -$13.50M(+32.4%) | $7.30M(-194.8%) | -$13.50M(-49.1%) |
Sep 1999 | - | -$7.70M(+63.8%) | -$26.50M(+81.5%) |
Jun 1999 | - | -$4.70M(-44.0%) | -$14.60M(+1.4%) |
Mar 1999 | - | -$8.40M(+47.4%) | -$14.40M(+41.2%) |
Dec 1998 | -$10.20M(+67.2%) | -$5.70M(-235.7%) | -$10.20M(+628.6%) |
Sep 1998 | - | $4.20M(-193.3%) | -$1.40M(-80.8%) |
Jun 1998 | - | -$4.50M(+7.1%) | -$7.30M(+5.8%) |
Mar 1998 | - | -$4.20M(-235.5%) | -$6.90M(+13.1%) |
Dec 1997 | -$6.10M(-70.0%) | $3.10M(-282.4%) | -$6.10M(-34.4%) |
Sep 1997 | - | -$1.70M(-58.5%) | -$9.30M(-36.3%) |
Jun 1997 | - | -$4.10M(+20.6%) | -$14.60M(-11.0%) |
Mar 1997 | - | -$3.40M(+3300.0%) | -$16.40M(-19.2%) |
Dec 1996 | -$20.30M(+11.5%) | -$100.00K(-98.6%) | -$20.30M(+12.2%) |
Sep 1996 | - | -$7.00M(+18.6%) | -$18.10M(-19.2%) |
Jun 1996 | - | -$5.90M(-19.2%) | -$22.40M(+18.5%) |
Mar 1996 | - | -$7.30M(-447.6%) | -$18.90M(+3.8%) |
Dec 1995 | -$18.20M(-11.2%) | $2.10M(-118.6%) | -$18.20M(-42.6%) |
Sep 1995 | - | -$11.30M(+370.8%) | -$31.70M(+20.5%) |
Jun 1995 | - | -$2.40M(-63.6%) | -$26.30M(+45.3%) |
Mar 1995 | - | -$6.60M(-42.1%) | -$18.10M(-11.7%) |
Dec 1994 | -$20.50M(-31.9%) | -$11.40M(+93.2%) | -$20.50M(+13.3%) |
Sep 1994 | - | -$5.90M(-201.7%) | -$18.10M(-0.5%) |
Jun 1994 | - | $5.80M(-164.4%) | -$18.20M(-42.8%) |
Mar 1994 | - | -$9.00M(0.0%) | -$31.80M(+5.6%) |
Dec 1993 | -$30.10M(+75.0%) | -$9.00M(+50.0%) | -$30.10M(+11.1%) |
Sep 1993 | - | -$6.00M(-23.1%) | -$27.10M(+8.8%) |
Jun 1993 | - | -$7.80M(+6.8%) | -$24.90M(+16.9%) |
Mar 1993 | - | -$7.30M(+21.7%) | -$21.30M(+23.8%) |
Dec 1992 | -$17.20M(+152.9%) | -$6.00M(+57.9%) | -$17.20M(+53.6%) |
Sep 1992 | - | -$3.80M(-9.5%) | -$11.20M(+51.4%) |
Jun 1992 | - | -$4.20M(+31.3%) | -$7.40M(+131.3%) |
Mar 1992 | - | -$3.20M | -$3.20M |
Dec 1991 | -$6.80M | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual CFO year-on-year change?
- What is Regeneron Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly CFO year-on-year change?
- What is Regeneron Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM CFO year-on-year change?
What is Regeneron Pharmaceuticals annual cash flow from operations?
The current annual CFO of REGN is $4.42B
What is the all time high annual CFO for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual cash flow from operations is $7.08B
What is Regeneron Pharmaceuticals annual CFO year-on-year change?
Over the past year, REGN annual cash flow from operations has changed by -$173.50M (-3.78%)
What is Regeneron Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of REGN is $1.05B
What is the all time high quarterly CFO for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly cash flow from operations is $3.41B
What is Regeneron Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, REGN quarterly cash flow from operations has changed by -$467.40M (-30.90%)
What is Regeneron Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of REGN is $3.95B
What is the all time high TTM CFO for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM cash flow from operations is $8.51B
What is Regeneron Pharmaceuticals TTM CFO year-on-year change?
Over the past year, REGN TTM cash flow from operations has changed by -$785.80M (-16.58%)